Subscribe to our RSS feeds RSS | Login | Register  
 

Pfizer's Saxton: healthcare professionals must lead CME

Matthew Arnold July 15, 2008

Pfizer med ed head Mike Saxton dismissed the notion that the company was bowing to pressure in its decision to eliminate direct support for CME programs sponsored by medical education and communication companies (MECCs).
 

MM&M Awards finalists unveiled next week

James Chase July 15, 2008

The judges' scores are in for the MM&M Awards 2008 submissions and the shortlist of finalists in each category will be revealed simultaneously in News Brief and at mmm-online.com next Tuesday, July 22.
 

Rx drug word-of-mouth occurs largely offline: study

Ben Comer July 11, 2008

Consumers engaging in prescription drug-related word-of-mouth tend to do it offline, according to a Keller Fay Group report.
 

PhRMA Code cracks down on gifts to docs

Matthew Arnold July 10, 2008

PhRMA revised its Code on Interactions with Healthcare Professionals to sharply limit gifts to physicians.
 

FDA consolidates drug application responses

Ben Comer July 09, 2008

The FDA will change the way it responds to drug applications, eliminating "approvable" and "not approvable" letters.
 

More docs using mobile devices: Manhattan Research

Ben Comer July 08, 2008

Mobile devices provide an increasing number of doctors with information and resources, from CME to drug reference databases, according to a Manhattan Research survey.
 

Novartis has eyes for Alcon

Matthew Arnold July 08, 2008

Novartis shelled out $10.4 billion to Nestle for a 25% stake in eye care company Alcon.
 

Chairman of LyonHeart announces retirement

Ben Comer July 07, 2008

Al Nickel, chairman of LyonHeart and the TBWA\WorldHealth network, has announced his retirement.
 

People news

Ben Comer July 03, 2008

Lisa Kowalski has joined Healthline Networks as senior director, strategic accounts for the West Coast. Kowalski was previously a senior global sales executive at Yahoo.
 

Product news

Ben Comer July 03, 2008

Abbott received FDA approval for its Xience V drug-coated stent, used to treat coronary artery disease. The stent is used to prop open a narrowed or blocked artery and releases a drug, everolimus, to prevent further blockage.